Bio Path Holdings Inc (BPTH)

[SJSTOCKSHARK]

Clint, The key for PPS increases in the short term is phase II results.

If we have similar results as in the combination phase I trial, complete dosing 25 patients and successfully apply for the accelerated FDA programs, your purchases will be golden.

http://www.fda.gov/forpatients/approvals/fast/ucm20041766.htm


Other potential PPS accelerants are a big pharma partnership or a high profile IND for treatment of a disease such as "triple negative breast cancer."

The caveat is management's ability to meet any of their projected time lines.